Sitour Management completed a €13m investment in OncoMal.

Sitour Management, an Austria-based investment/management company, completed a €13m investment in OncoMal, a Danish cancer research and development company. The investment is crucial working capital intended to move the therapies and diagnostics through expensive and critical clinical development milestones. Reaching these milestones dramatically increases the company's valuation.